Porcine Heart Valve

A bioprosthetic valve obtained from pigs, which have an average 9-year lifespan (compared to 50,000 simulated years with mechanical valves), but don’t require anti-coagulation with Coumadin. Because of the limited lifespan, porcine valves are usually implanted on patients age 55 and above
References in periodicals archive ?
The Company also distributes the CryoLife-O'Brien(R) stentless porcine heart valve, which is CE marked for distribution within the European Community.
CryoLife says SynerGraft incorporates the use of a porcine heart valve which has been depopulated of its porcine heart valve cells, providing a collagen matrix that has the normal functionality of a human heart valve, with the potential to be repopulated with the recipient's own cells.
The Company also distributes the CryoLife-O'Brien(R) stentless porcine heart valve and the SG Model 100 vascular graft, which are CE marked for distribution within the European Community.
Atlanta, GA, announced that two human females have each received a tissue-engineered SynerGraft porcine heart valve in the aortic position.
David successfully implanted the 20,000th Toronto Stentless Porcine Heart Valve (Toronto SPV(R) valve) at Toronto General Hospital (TGH), marking a milestone for both St.
Under terms of the grant, CryoLife says its scientists will conduct advanced studies and animal testing on the feasibility of a new biologic human heart vale replacement which incorporates a porcine heart valve collagen matrix that can be "seeded" with human cells from the recipient to create a living autograft heart valve for human heart valve replacement surgery.
The results from research in animals suggests that CryoLife's SynerGraft process, which is based on the use of a depopulated porcine heart valve, will repopulate with the recipient's own cells.
CryoLife's SynerGraft technology is based on the use of a porcine heart valve, which is depopulated of its cells and in animal studies has demonstrated the repopulation of the tissue-engineered heart valve with the recipient's own cells.
In August 1999, CryoLife announced the first human implants of its tissue-engineered SynerGraft(R) porcine heart valve at the Prince Charles Hospital in Brisbane, Australia.
NYSE:CRY), the leader in the development and commercialization of living human tissue implantable devices and a manufacturer and distributor of stentless heart valves and surgical adhesives, today announced that two human females had each received a tissue-engineered SynerGraft(R) porcine heart valve in the aortic position.
TO MARY IN WYOMING: Porcine heart valves (made from pig hearts) have been used to replace narrowed and/or leaking human aortic and mitral valves since about 1965.
The company also manufactures CryoLife-O'Brien(R) and CryoLife-Ross(TM) stentless porcine heart valves which are distributed within the European Community.

Full browser ?